Machine Learning – A Game-Changer In The Pharma Industry
Machine learning, when it comes to the pharma sector, had a value of almost $1.2 billion in 2021, and it is anticipated to touch...
Impact of AI On The Pharmaceutical Industry Sparks Debates
Artificial Intelligence remains a hot topic in the pharma spectrum, and the current ChatGPT wave has begun many more conversations. As of now, there...
Advancing Pharma Logistics – Smart Contracts And Blockchain
Researchers from Sweden have identified the advantages of employing smart contracts on blockchain platforms within the pharmaceutical supply chain to combat counterfeit drugs. Despite...
Role of Blockchain In Pharmaceutical Supply Chain Efficiency
In late 2020, Pfizer, a drug manufacturer, faced challenges in meeting its Covid-19 vaccine production targets due to quality issues with raw materials, causing...
Harnessing Blockchain Technology For Better Pharma Functions
The pharmaceutical sector happens to be significant for enhancing and sustaining public health. It is responsible when it comes to exploring, developing, producing, as...
Next Decade To Witness Automation Driving Biopharma Sector
One of the reports concerning automation in the biopharmaceutical sector has gone on to show that the market is estimated to grow at a...
Elevating Vaccine Stability Through Predicting mRNA Degrades
Messenger ribonucleic acid (mRNA) as a therapeutic method is gaining traction due to its ease of production and promising results.
mRNA-based vaccines, for example, have...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...